Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Breast Cancer Non-invasive Breast Cancer”

106 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 106 results

Not applicableLooking for participantsNCT06716073
What this trial is testing

Long-Term Outcomes of Endoscopic-assisted vs Conventional Breast-conserving Surgery in Breast Cancer Patients After Neoadjuvant Therapy: a Randomized, Multicenter, Open Label, Non-inferiority Trial

Who this might be right for
Breast Cancer Invasive
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 1,380
Not applicableLooking for participantsNCT07071272
What this trial is testing

Non-inferiority Study of Contrast-enhanced Digital Mammography (CEDM) vs Magnetic Resonance Imaging (MRI) in Terms of Diagnostic Accuracy in Patients Undergoing Preoperative Staging of Established Invasive Breast Cancer

Who this might be right for
Breast Cancer
Azienda Ospedaliera Universitaria Integrata Verona 216
Testing effectiveness (Phase 2)Study completedNCT05960201
What this trial is testing

Diagnostic Performance of [18F]FES PET/CT for Axillary LN Metastasis in Invasive Lobular Carcinoma

Who this might be right for
Carcinoma, Lobular
Asan Medical Center 23
Not applicableActive Not RecruitingNCT06053775
What this trial is testing

Non-Invasive Brain Stimulation and Cognitive Training for Depressive Symptomatology Related to Breast Cancer (ONCODEP)

Who this might be right for
Depressive SymptomsCognitive Impairment
University of Santiago de Compostela 82
Not applicableUnknownNCT04758416
What this trial is testing

Study on the Value of Non-invasive Dual-Pet Information in Subtype of Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Fudan University 50
Not applicableNot Yet RecruitingNCT07398118
What this trial is testing

CRYO-1: Cryoablation in Elderly Patients With Early-Stage Breast Cancer.

Who this might be right for
Breast Cancer Stage IBreast Cancer Early Stage Breast Cancer (Stage 1-3)
St. Antonius Hospital 61
Not applicableStudy completedNCT05695859
What this trial is testing

99mTc-DARPinG3 SPECT/CT for Non-invasive HER2-AX in Breast Cancer With Metastatic Lymph Nodes Before Targeted Therapy

Who this might be right for
Breast Cancer Female
Tomsk National Research Medical Center of the Russian Academy of Sciences 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT02834013
What this trial is testing

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

Who this might be right for
Acinar Cell CarcinomaAdenoid Cystic CarcinomaAdrenal Cortical Carcinoma+91 more
National Cancer Institute (NCI) 798
Not applicableUnknownNCT05868252
What this trial is testing

Molecular Analysis of the Sloane Project

Who this might be right for
DCISLCISAtypical Ductal Hyperplasia+1 more
King's College London 1,500
Testing effectiveness (Phase 2)UnknownNCT05619016
What this trial is testing

[68Ga]Ga-ABY-025 PET for Quantification of HER2-status in Solid Tumors

Who this might be right for
Esophageal NeoplasmsGastric Neoplasms MalignantBreast Cancer+1 more
Karolinska University Hospital 72
Early research (Phase 1)Study completedNCT00004074
What this trial is testing

Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu

Who this might be right for
Advanced Adult Primary Liver CancerAnaplastic Thyroid CancerBone Metastases+124 more
National Cancer Institute (NCI) 15
Testing effectiveness (Phase 2)UnknownNCT02587689
What this trial is testing

Phase I/II Study of Anti-Mucin1 (MUC1) CAR T Cells for Patients With MUC1+ Advanced Refractory Solid Tumor

Who this might be right for
Hepatocellular CarcinomaNon-small Cell Lung CancerPancreatic Carcinoma+1 more
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 20
Not applicableUnknownNCT03374826
What this trial is testing

PET-MRI for Axillary Staging in Node Negative Breast Cancer Patients

Who this might be right for
Breast CancerBreast NeoplasmsBreast Diseases
Maastricht University Medical Center 125
Not applicableUnknownNCT05887154
What this trial is testing

Non Surgical Treatment (Microwave Ablation) of Breast Cancer

Who this might be right for
Breast Cancer Stage I
University Medical Center Groningen 15
Testing effectiveness (Phase 2)UnknownNCT02839954
What this trial is testing

CAR-pNK Cell Immunotherapy in MUC1 Positive Relapsed or Refractory Solid Tumor

Who this might be right for
Hepatocellular CarcinomaNon-small Cell Lung CancerPancreatic Carcinoma+4 more
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 10
Testing effectiveness (Phase 2)Study completedNCT06695039
What this trial is testing

Diagnostic Performance of [18F]FES PET/CT for Axillary LN Metastasis in ER-positive Breast Cancer

Who this might be right for
Breast Cancer Invasive
Asan Medical Center 71
Testing effectiveness (Phase 2)Looking for participantsNCT04084730
What this trial is testing

Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer

Who this might be right for
Invasive Ductal Breast CarcinomaInvasive Ductal Carcinoma, BreastDCIS+3 more
Memorial Sloan Kettering Cancer Center 280
Not applicableUnknownNCT06357338
What this trial is testing

Differential Expression and Potential Value of c-MYC in Non-Invasive and Invasive Mammary Carcinoma

Who this might be right for
Invasive Breast Cancer
Marwa Mahmoud Hassan 70
Not applicableUnknownNCT02195076
What this trial is testing

Non Invasive Detection of Lung and Breast Cancer by Odor Signature

Who this might be right for
Lung CancerBreast Cancer
BioSense Medical LTD 400
Not applicableNot Yet RecruitingNCT06950671
What this trial is testing

Role of Triggering Receptor Expressed on Myeloid Cells (TREM-1) as a Novel Biomarker in Human Epidermal Growth Factor Receptor -2 (HER-2) Negative Breast Cancer: a Molecular and Clinical Study

Who this might be right for
Breast Cancer Stage IBreast Cancer Stage IIBreast Cancer Stage III+1 more
Rahma Esam Salama Esawi 1
Load More Results